According to the notice issued by the State Food and Drug Administration, it is required to further strengthen the administration of purchase and administration of codeine compound oral solution, compound licorice tablets and compound diphenoxylate tablets.

In order to further strengthen the management of the purchase and sale of these drugs, the notice pointed out that it is necessary to strengthen the sales management of drug manufacturers. The relevant drug manufacturers shall select and determine the pharmaceutical wholesale enterprises with relatively stable business relationships (15-130.html) according to the quality management level, credit status, information level, and logistics capabilities, and distribute the above-mentioned drugs of the enterprise. Pharmaceutical production companies can only sell the above-mentioned pharmaceuticals produced by the company directly to wholesale enterprises established by the company. When a production enterprise signs a purchase and sales contract with a wholesale enterprise, it shall stipulate that the requirements for sales of compound preparations containing special drugs shall be strictly in accordance with state regulations as the contents of the contract, and shall strengthen the supervision over the implementation of the agreement by the wholesale enterprise.

The circular emphasized that strict management of purchases and sales of pharmaceutical companies must be implemented. Wholesale enterprises that directly purchase pharmaceuticals from manufacturing enterprises may sell pharmaceuticals to other wholesale and retail enterprises and medical institutions; those purchased from wholesale enterprises may only sell to retail enterprises and medical institutions in the province (region, city). . In the drug retailing sector, the above-mentioned drugs are included in prescription drugs that must be sold by prescription, and are strictly sold by prescriptions issued by doctors. If it finds that it exceeds the normal medical needs, it shall immediately report to the local food and drug supervision and administration department if it purchases the above-mentioned drugs in large quantities or multiple times.

The notice requires that the supervision of drug purchase and sales be strengthened. Food and drug regulatory authorities at all levels must intensify supervision and inspection, urge enterprises to strictly review suppliers' qualifications or sellers' qualifications, standardize purchase and sales channels and bill management, earnestly implement rules for warehousing and review, check systems, and prohibit cash transactions and other regulations to prevent drugs. Inflow into illegal channels; it is necessary to strengthen supervision and guidance on the classification management of prescription drugs and non-prescription drugs in retail pharmacies, and to prevent drug misappropriation and misuse.